(Q40147752)

17 September 2017

title

Signal transduction mediated by endostatin directly modulates cellular function of lung cancer cells in vitro (English)

1 reference

17 September 2017

Ri Cui

1

1 reference

17 September 2017

Rina Ohashi

2

1 reference

17 September 2017

Fumiyuki Takahashi

3

1 reference

17 September 2017

Masakata Yoshioka

4

1 reference

17 September 2017

Shigeru Tominaga

5

1 reference

17 September 2017

Shinichi Sasaki

6

1 reference

17 September 2017

Tao Gu

7

1 reference

17 September 2017

Yumiko Takagi

8

1 reference

17 September 2017

Kazuhisa Takahashi

9

1 reference

17 September 2017

publication date

5 April 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

98

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

830-837

1 reference

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Anti-angiogenic agents: clinical trial design and therapies in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Collagen XVIII/endostatin structure and functional role in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Cell surface glypicans are low-affinity endostatin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Expression and function of fibronectin binding integrins on rat mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Integrins: emerging paradigms of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

N-glycosylation of the beta-propeller domain of the integrin alpha5 subunit is essential for alpha5beta1 heterodimerization, expression on the cell surface, and its biological function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

Endostatin is a potential inhibitor of Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00459.X

10.1111/J.1349-7006.2007.00459.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference